Alzamend Neuro, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Alzamend Neuro, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2020 to Q1 2024.
  • Alzamend Neuro, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending April 30, 2024 was $15.8M, a 45.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $15.8M +$4.95M +45.8% Apr 30, 2024 10-K 2024-07-30
Q1 2023 $10.8M +$736K +7.31% Apr 30, 2023 10-K 2024-07-30
Q1 2022 $10.1M +$5.72M +131% Apr 30, 2022 10-K 2023-07-27
Q1 2021 $4.35M +$1.51M +53.1% Apr 30, 2021 10-K 2022-07-19
Q1 2020 $2.84M Apr 30, 2020 10-K 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.